The efficacy of Mizoribine for scleroderma of systemic sclerosis.
Not Applicable
Recruiting
- Conditions
- systemic sclerosis
- Registration Number
- JPRN-UMIN000004162
- Lead Sponsor
- Faculty of Life Sciences, Kumamoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
The cases of hypersensitivity for Mizoribine.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method skin screlosis
- Secondary Outcome Measures
Name Time Method